Lanean...
Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients
Ulcerative Colitis (UC) is an inflammatory bowel disease typically affecting the colon. Patients with active UC have elevated tumor necrosis factor (TNF) concentrations in serum and colonic tissue. Infliximab is a monoclonal antibody directed against TNF and binds with high affinity. Target-mediated...
Gorde:
| Argitaratua izan da: | J Pharmacokinet Pharmacodyn |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer US
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6868113/ https://ncbi.nlm.nih.gov/pubmed/31489538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10928-019-09652-5 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|